רמיטנס 5

Država: Izrael

Jezik: hebrejski

Izvor: Ministry of Health

Aktivni sastojci:

RAMIPRIL 5 MG

Dostupno od:

RAFA LABORATORIES LTD

ATC koda:

C09AA05

Farmaceutski oblik:

CAPSULES

Administracija rute:

PER OS

Proizveden od:

RAFA LABORATORIES LTD, JERUSALEM

Terapijska grupa:

RAMIPRIL

Terapijske indikacije:

Hypertension congestive heart failure reduction of mortality in patients after MI with left ventricular dysfunction. For reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous MI unstable angina or multivessel CABG or multivessel PTCA) stroke or peripheral vascular disease. Also for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : hypertension (systolic blood pressure > 160 mmHg or diastolic pressure > 90 mmHg) high total cholesterol (>5.2 mmol/L) low HDL ( <0.9 mmol/L) current smoker known microalbuminuria clinical evidence of previous vascular disease. Prevention of progressive renal failure in patients suffering from impaired renal function.

Datum autorizacije:

2009-08-01